• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Clin Transl Neurol . Structural brain changes in post-acute COVID-19 patients with persistent olfactory dysfunction

tetano

Editor, Senior Moderator
Ann Clin Transl Neurol


. 2022 Dec 16.
doi: 10.1002/acn3.51710. Online ahead of print.
Structural brain changes in post-acute COVID-19 patients with persistent olfactory dysfunction


Anna Campabadal[SUP] #[/SUP][SUP] 1 2 [/SUP], Javier Oltra[SUP] #[/SUP][SUP] 1 2 [/SUP], Carme Junqué[SUP] 1 2 [/SUP], Núria Guillen[SUP] 3 [/SUP], María Ángeles Botí[SUP] 3 [/SUP], Roser Sala-Llonch[SUP] 4 [/SUP], Gemma C Monté-Rubio[SUP] 1 2 [/SUP], Gema Lledó[SUP] 5 [/SUP], Nuria Bargalló[SUP] 6 [/SUP], Lorena Rami[SUP] 3 [/SUP], Raquel Sánchez-Valle[SUP] 3 [/SUP], Bàrbara Segura[SUP] 1 2 [/SUP]



Affiliations

Abstract

Objective: This research aims to study structural brain changes in patients with persistent olfactory dysfunctions after coronavirus disease 2019 (COVID-19).
Methods: COVID-19 patients were evaluated using T1-weighted and diffusion tensor imaging (DTI) on a 3T MRI scanner, 9.94 ± 3.83 months after COVID-19 diagnosis. Gray matter (GM) voxel-based morphometry was performed using FSL-VBM. Voxelwise statistical analysis of the fractional anisotropy, mean diffusivity (MD), radial diffusivity (RD), and axial diffusivity was carried out with the tract-based spatial statistics in the olfactory system. The smell identification test (UPSIT) was used to classify patients as normal olfaction or olfactory dysfunction groups. Intergroup comparisons between GM and DTI measures were computed, as well as correlations with the UPSIT scores.
Results: Forty-eight COVID-19 patients were included in the study. Twenty-three were classified as olfactory dysfunction, and 25 as normal olfaction. The olfactory dysfunction group had lower GM volume in a cluster involving the left amygdala, insular cortex, parahippocampal gyrus, frontal superior and inferior orbital gyri, gyrus rectus, olfactory cortex, caudate, and putamen. This group also showed higher MD values in the genu of the corpus callosum, the orbitofrontal area, the anterior thalamic radiation, and the forceps minor; and higher RD values in the anterior corona radiata, the genu of the corpus callosum, and uncinate fasciculus compared with the normal olfaction group. The UPSIT scores for the whole sample were negatively associated with both MD and RD values (p-value ≤0.05 FWE-corrected).
Interpretation: There is decreased GM volume and increased MD in olfactory-related regions explaining prolonged olfactory deficits in post-acute COVID-19 patients.
 
Back
Top Bottom